MedPath

The effect of Diet and Exercise on Fatty Liver Disease

Not Applicable
Conditions
on-alcoholic fatty liver disease (NAFLD).
Fatty (change of) liver, not elsewhere classified
K76.0
Registration Number
IRCT20210808052106N1
Lead Sponsor
Iran Health Insurance Organization
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Patients with non-alcoholic fatty liverdisease

Exclusion Criteria

Cardiovascular, thyroid, renal, inflammatory, autoimmune, hepatitis B and C, hereditary hemochromatosis, Wilson
Alcohol consumers

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Aspartate trans amylase. Timepoint: At the beginning of the study and 12 weeks after the intervention. Method of measurement: Spectrophotometric method.;Alanine amino transferase. Timepoint: At the beginning of the study and 12 weeks after the intervention. Method of measurement: Spectrophotometric method.;Body Mass index. Timepoint: At the beginning of the study and 12 weeks after the intervention. Method of measurement: Divide weight by height squared.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath